NCT02714920View on ClinicalTrials.gov

DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD)

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Head CancerNeck Cancer
Interventions
OTHER

CHEMRAD assay

CHEMRAD is a new biomarker research strategy based on three assays that enables the functional characterization of DNA repair capacities.

Trial Locations (4)

38043

CHU Grenoble - Hôpital Michallon, Grenoble

69004

Hospices Civils de Lyon - Hôpital de la Croix Rousse, Lyon

69008

Centre Léon Bérard, Lyon

Unknown

Hospices Civils de Lyon, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02714920 - DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD) | Biotech Hunter | Biotech Hunter